PRJNA510621
Genomic Resistance Mechanisms to  a single dose of PD-1 Blockade
Paired DNA WES data from post treatment (D21) tumors and Recurrence tumors for three patients that recurred on the neoadjuvant pembrolizumab clinical trial NCT02434354.